We subsequently created a more unique probe, [18F]CFA, which was used in the current examine To judge dCK exercise in tumors when treated with a small molecule dCK inhibitor. This probe is likewise becoming researched in the medical trial at our establishment To judge alterations in dCK action following cancer immunotherapy 18. PET probes in precli